Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Enbrel, Remicade Anti-TNF Class Labeling Debated By FDA Advisory Cmte.

Aug 20 2001

• By The Pink Sheet

Related Content

Amgen Kineret Needs Enbrel Combo Study And Combo Use Warning - Cmte

Aug 20 2001

Centocor Remicade Black Box MD Visits Will Be 85% Complete By Aug. 31

Aug 20 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window